Q3 2025 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2025-11-14 · accession 0001892688-25-000193
$391.0M
Reported value
130
Positions
2025-09-30
Period end
The Brief · DIADEMA PARTNERS LP · Q3 2025
AI · grounded in 13F
DIADEMA PARTNERS LP closed its position in Amgen Inc AMGN, reducing exposure by $31.89M. The fund established new positions in Bristol-Myers Squibb Co BMY for $13.98M and SPDR S&P 500 ETF TR SPY for $13.32M. Additionally, the fund increased its holdings in Regeneron Pharmaceuticals REGN by 437.9% and Viking Therapeutics Inc VKTX by 203.2%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N90064101 | QURE | UNIQURE NV | $17.5M | 4.48% | 300,000 | PUT | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $17.0M | 4.34% | 30,160 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $13.3M | 3.41% | 20,000 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $13.2M | 3.37% | 100,000 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $12.0M | 3.07% | 177,330 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $11.5M | 2.95% | 212,877 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $10.6M | 2.72% | 405,100 | CALL | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $8.9M | 2.28% | 222,100 | CALL | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $8.7M | 2.23% | 200,100 | CALL | SOLE |
| 45337C102 | INCY | INCYTE CORP | $8.5M | 2.17% | 100,000 | CALL | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $8.1M | 2.08% | 470,200 | CALL | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $8.1M | 2.08% | 180,000 | CALL | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $7.9M | 2.01% | 218,285 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $7.6M | 1.95% | 10,000 | PUT | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $7.3M | 1.86% | 112,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.8M | 1.75% | 131,400 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $6.8M | 1.73% | 100,000 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $6.6M | 1.69% | 50,000 | PUT | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $6.5M | 1.67% | 100,000 | CALL | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $6.1M | 1.57% | 254,252 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $5.9M | 1.50% | 130,000 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $5.6M | 1.43% | 1,039,500 | CALL | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $5.5M | 1.42% | 100,000 | PUT | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $5.5M | 1.40% | 27,572 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.3M | 1.36% | 100,000 | PUT | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $5.3M | 1.36% | 37,754 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $5.1M | 1.30% | 193,689 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $5.1M | 1.29% | 127,400 | CALL | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $4.6M | 1.17% | 10,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $4.5M | 1.16% | 300,000 | PUT | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $4.5M | 1.16% | 124,384 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.5M | 1.15% | 150,000 | CALL | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $4.3M | 1.09% | 75,000 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $4.1M | 1.06% | 150,000 | CALL | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $3.8M | 0.96% | 200,000 | CALL | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $3.7M | 0.95% | 100,000 | CALL | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $3.7M | 0.95% | 123,300 | PUT | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $3.5M | 0.90% | 41,620 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.4M | 0.87% | 698,400 | CALL | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $3.4M | 0.87% | 51,185 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.86% | 50,000 | CALL | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $3.4M | 0.86% | 196,500 | CALL | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.1M | 0.80% | 1,520,200 | CALL | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $3.0M | 0.78% | 23,140 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $2.9M | 0.74% | 31,400 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $2.9M | 0.73% | 200,000 | CALL | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $2.8M | 0.71% | 150,900 | PUT | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.8M | 0.71% | 59,079 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $2.6M | 0.67% | 102,100 | CALL | SOLE |
| 810648105 | SCPH | SCPHARMACEUTICALS INC | $2.6M | 0.67% | 462,000 | CALL | SOLE |
| 60770K107 | MRNA | MODERNA INC | $2.6M | 0.66% | 100,000 | PUT | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $2.6M | 0.66% | 612,300 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $2.6M | 0.65% | 64,250 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.4M | 0.62% | 323,159 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $2.3M | 0.60% | 516,300 | CALL | SOLE |
| 039697107 | ARDX | ARDELYX INC | $2.2M | 0.56% | 400,000 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $2.2M | 0.56% | 26,500 | PUT | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.2M | 0.56% | 60,748 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $2.2M | 0.55% | 824,800 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $2.2M | 0.55% | 300,000 | CALL | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $2.2M | 0.55% | 72,079 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $1.9M | 0.49% | 89,000 | CALL | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $1.8M | 0.46% | 120,000 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $1.8M | 0.46% | 90,000 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $1.8M | 0.45% | 100,000 | CALL | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.7M | 0.45% | 463,000 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $1.7M | 0.43% | 225,200 | CALL | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $1.6M | 0.41% | 136,700 | CALL | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.6M | 0.40% | 100,000 | CALL | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.5M | 0.39% | 74,700 | CALL | SOLE |
| 695127100 | PCRX | PACIRA BIOSCIENCES INC | $1.5M | 0.39% | 58,926 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $1.5M | 0.38% | 173,500 | CALL | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.4M | 0.36% | 97,813 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $1.4M | 0.35% | 25,000 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $1.4M | 0.35% | 50,100 | PUT | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $1.4M | 0.35% | 50,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $1.4M | 0.35% | 100,000 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $1.3M | 0.33% | 30,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $1.2M | 0.32% | 105,891 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $1.2M | 0.32% | 139,800 | CALL | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $1.2M | 0.32% | 349,789 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $1.2M | 0.30% | 300,000 | CALL | SOLE |
| 21900C308 | CRMD | CORMEDIX INC | $1.2M | 0.30% | 100,000 | PUT | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $1.1M | 0.29% | 212,475 | Common | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS INC | $1.1M | 0.27% | 22,348 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $1.0M | 0.27% | 300,000 | CALL | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $1.0M | 0.26% | 131,400 | CALL | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $985,000 | 0.25% | 50,000 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $924,051 | 0.24% | 2,506,921 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $899,587 | 0.23% | 48,811 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $885,995 | 0.23% | 90,500 | CALL | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $785,345 | 0.20% | 85,830 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $721,629 | 0.18% | 135,900 | CALL | SOLE |
| 81642T209 | SLS | SELLAS LIFE SCIENCES GROUP I | $644,000 | 0.16% | 400,000 | CALL | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $608,489 | 0.16% | 74,753 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $591,062 | 0.15% | 185,286 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $516,600 | 0.13% | 20,000 | Common | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $512,620 | 0.13% | 272,670 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $511,141 | 0.13% | 315,519 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $455,086 | 0.12% | 27,800 | CALL | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $429,000 | 0.11% | 300,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $402,628 | 0.10% | 136,023 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $368,500 | 0.09% | 50,000 | PUT | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $355,710 | 0.09% | 100,200 | CALL | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $335,888 | 0.09% | 157,694 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $333,000 | 0.09% | 150,000 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $312,354 | 0.08% | 140,700 | CALL | SOLE |
| 171126204 | PTHS | PELTHOS THERAPEUTICS INC | $293,944 | 0.08% | 10,498 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $276,405 | 0.07% | 9,189 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $274,341 | 0.07% | 136,488 | Common | SOLE |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $252,919 | 0.06% | 21,452 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $244,500 | 0.06% | 50,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $244,061 | 0.06% | 187,739 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $227,676 | 0.06% | 43,616 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $221,444 | 0.06% | 71,204 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $187,137 | 0.05% | 26,100 | CALL | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $135,494 | 0.03% | 7,324 | Common | SOLE |
| 05380C102 | RCEL | AVITA MEDICAL INC | $128,261 | 0.03% | 25,100 | CALL | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $100,893 | 0.03% | 3,295 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $92,844 | 0.02% | 128,700 | CALL | SOLE |
| 140755307 | TVRD | TVARDI THERAPEUTICS INC | $85,149 | 0.02% | 2,185 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $81,164 | 0.02% | 39,400 | PUT | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $54,971 | 0.01% | 76,200 | PUT | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $28,809 | 0.01% | 9,900 | PUT | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $18,007 | 0.00% | 1,100 | PUT | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $15,820 | 0.00% | 11,300 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $11,493 | 0.00% | 19,000 | CALL | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $7,735 | 0.00% | 700 | PUT | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $7,170 | 0.00% | 300 | PUT | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $2,768 | 0.00% | 1,046 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.